Inventor · disambiguated record
Qian Zhao
Also filed as: ZHAO QIAN
91 granted patents·17 pending applications·629 citations·filing 2003–2025
99Inventor score
Files withARRAY BIOPHARMA INC38BRISTOL MYERS SQUIBB CO16NOVARTIS AG16HANS JEREMY4MIRATI THERAPEUTICS INC4
Top patents by PatentIndex Score
108 records- 0198US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0297US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 0397US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 0497US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 0597US9732119B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 15, 2017·14 cites·8 claims
- 0697US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 0796US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0896US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0995US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 1095US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 1195US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 1293US10780073B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·7 cites·24 claims
- 1393US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 1492US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 1592US11098051B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Aug 24, 2021·5 cites·19 claims
- 1692US10160764B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 25, 2018·11 cites·29 claims
- 1792US8445490B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2011·Granted May 21, 2013·11 cites·2 claims
- 1891US11453677B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2020·Granted Sep 27, 2022·2 cites·14 claims
- 1991US9693989B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2013·Granted Jul 4, 2017·13 cites·28 claims
- 2090US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 2190US8648087B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesLYSSIKATOS JOSEPH P·Filed 2006·Granted Feb 11, 2014·24 cites·37 claims
- 2289US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 2389US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 2488US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 2588US9944678B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 17, 2018·8 cites·2 claims
- 2688US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 2787US10450347B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 22, 2019·6 cites·23 claims
- 2887US10358463B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·7 cites·15 claims
- 2987US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 3087US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 3185US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 3285US8916702B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 23, 2014·4 cites·14 claims
- 3385US8268871B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2010·Granted Sep 18, 2012·7 cites·10 claims
- 3484US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 3584US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 3684US10221194B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 5, 2019·2 cites·1 claims
- 3784US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 3884US8765944B2Compounds for the treatment of hepatitis CSUN LI-QIANG·Filed 2011·Granted Jul 1, 2014·7 cites·9 claims
- 3984US2025011334A1Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4083US8623895B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Jan 7, 2014·4 cites·104 claims
- 4183US8586584B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2010·Granted Nov 19, 2013·7 cites·15 claims
- 4282US11629149B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 4382US9102639B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Granted Aug 11, 2015·3 cites·22 claims
- 4482US8580828B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Nov 12, 2013·5 cites·35 claims
- 4582US8324257B2Mitotic kinesin inhibitors and methods of use thereofAHRENDT KATERI·Filed 2007·Granted Dec 4, 2012·7 cites·37 claims
- 4682US8278314B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2008·Granted Oct 2, 2012·6 cites·14 claims
- 4781US12171739B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 4881US10858366B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 8, 2020·3 cites·20 claims
- 4981US7452895B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2004·Granted Nov 18, 2008·14 cites·17 claims
- 5080US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Qian Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →